1. Home
  2. EYPT vs ARI Comparison

EYPT vs ARI Comparison

Compare EYPT & ARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$12.86

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo Apollo Commercial Real Estate Finance Inc

ARI

Apollo Commercial Real Estate Finance Inc

HOLD

Current Price

$10.42

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYPT
ARI
Founded
1987
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Real Estate Investment Trusts
Sector
Industrials
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2005
2009

Fundamental Metrics

Financial Performance
Metric
EYPT
ARI
Price
$12.86
$10.42
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
$31.80
$11.00
AVG Volume (30 Days)
1.2M
1.1M
Earning Date
03-04-2026
04-23-2026
Dividend Yield
N/A
9.94%
EPS Growth
N/A
183.51
EPS
N/A
0.81
Revenue
$7,539,000.00
$271,589,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1,031.72
N/A
P/E Ratio
N/A
$12.45
Revenue Growth
N/A
N/A
52 Week Low
$3.91
$7.70
52 Week High
$19.11
$11.21

Technical Indicators

Market Signals
Indicator
EYPT
ARI
Relative Strength Index (RSI) 36.53 48.89
Support Level $12.05 $9.60
Resistance Level $13.32 $10.95
Average True Range (ATR) 1.01 0.22
MACD -0.33 -0.03
Stochastic Oscillator 3.45 52.59

Price Performance

Historical Comparison
EYPT
ARI

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses on developing and commercializing innovative therapeutics for serious retinal diseases. It develops therapies for serious retinal diseases to provide durable treatments that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained release product candidate for retinal diseases with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

Share on Social Networks: